↑ 薬物リストへ　← 戻る

Human primary retinal pigment epithelial (hurpe) cells    (DrugBank: -)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
90網膜色素変性症1

90. 網膜色素変性症　［臨床試験数：103，薬物数：158（DrugBank：42），標的遺伝子数：52，標的パスウェイ数：107］
Searched query = "Retinitis pigmentosa", "Rod dystrophy", "Rod-Cone Dystrophy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 103 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03566147
(ClinicalTrials.gov)		August 1, 201812/6/2018Treatment of RP and LCA by Primary RPE TransplantationTreatment of Retinitis Pigmentosa and Leber Congenital Amaurosis by Primary Retinal Pigment Epithelial Cells TransplantationLeber Congenital Amaurosis, Retinitis PigmentosaBiological: Human primary Retinal Pigment Epithelial (HuRPE) cellsEyecure Therapeutics Inc.Beijing Tongren HospitalUnknown status18 Years70 YearsAll30Early Phase 1China